The chemical protective effect of isorhamnetin on colon cancer is related to its anti-inflammatory activity, inhibition of carcinogenic Src activity, and corresponding loss of nuclear β-catenin, which depend on the expression of C-terminal Src kinase (CSK) [36]. The gene discussed is SRC; the disease is malignant colon neoplasm.